Literature DB >> 15021972

Histopathological features of murine systemic vasculitis caused by Candida albicans extract--an animal model of Kawasaki disease.

K Takahashi1, T Oharaseki, M Wakayama, Y Yokouchi, S Naoe, H Murata.   

Abstract

OBJECTIVE AND
DESIGN: We examined the histopathological features of systemic vasculitis caused in mice by injection of a Candida albicans ( C. albicans) extract and investigated the principal genetic roles in the development of vasculitis.
MATERIALS AND METHODS: C. albicans extract was injected intraperitoneally for five consecutive days in the 1st and 5th weeks to CD-1, C57BL/6N, C3H/HeN, BALB/cAnN, DBA/2N and CBA/JN mice. At week 8, mice were killed, and histological examination was performed by light microscopy.
RESULTS: Arteritis had developed in 66% of CD-1 mice. The extramural coronary arteries and aortic root close to the orifice of coronary arteries were most frequently involved. Histologically, the characteristic feature of the arteritis was proliferative and granulomatous inflammation accompanied by numerous macrophages, lymphocytes, plasma cells and neutrophils. Fibrocellular intimal thickening with destruction of the internal elastic lamina and media was also observed. Five mouse strains after injection of C. albicans extract were clearly classified into a resistant group (CBA/JN, DBA/2N and BALB/cAnN mice) and a sensitive group (C3H/HeN and C57BL/6N mice). The inbred mouse strains which showed the same histocompatibility-2 (H-2) haplotype exhibited a different susceptibility to development of vasculitis.
CONCLUSION: This arteritis murine model shows unique histological features that have not been observed in other animal vasculitis models and it most closely resembles Kawasaki disease in humans. The genetic control of susceptibility to induction of vasculitis by the C. albicans extract is dependent to the mouse strains, but is not linked to the H-2 loci.

Entities:  

Mesh:

Year:  2004        PMID: 15021972     DOI: 10.1007/s00011-003-1225-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  18 in total

1.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 2.  Kawasaki disease: insights into pathogenesis and approaches to treatment.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

3.  Dectin-2-induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis.

Authors:  Chie Miyabe; Yoshishige Miyabe; Laura Bricio-Moreno; Jeffrey Lian; Rod A Rahimi; Noriko N Miura; Naohito Ohno; Yoichiro Iwakura; Tamihiro Kawakami; Andrew D Luster
Journal:  J Clin Invest       Date:  2019-06-06       Impact factor: 14.808

4.  Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase.

Authors:  Henry S Su; Matthias Nahrendorf; Peter Panizzi; Michael O Breckwoldt; Elisenda Rodriguez; Yoshiko Iwamoto; Elena Aikawa; Ralph Weissleder; John W Chen
Journal:  Radiology       Date:  2011-11-14       Impact factor: 11.105

Review 5.  Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery.

Authors:  Nobutaka Noto; Akiko Komori; Mamoru Ayusawa; Shori Takahashi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

6.  The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease.

Authors:  Chisato Shimizu; Toshiaki Oharaseki; Kei Takahashi; Aubri Kottek; Alessandra Franco; Jane C Burns
Journal:  Hum Pathol       Date:  2012-09-03       Impact factor: 3.466

7.  Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Tomokazu Nagao; Yuki Yokouchi; Hitomi Yamada; Noriko Nagi-Miura; Naohito Ohno; Tsutomu Saji; Tomio Okazaki; Kazuo Suzuki
Journal:  Pediatr Rheumatol Online J       Date:  2011-09-29       Impact factor: 3.054

8.  Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis.

Authors:  I-Chun Lin; Ho-Chang Kuo; Ying-Jui Lin; Feng-Shen Wang; Lin Wang; Shun-Chen Huang; Shao-Ju Chien; Chien-Fu Huang; Chih-Lu Wang; Hong-Ren Yu; Rong-Fu Chen; Kuender D Yang
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

9.  A Model of Left Ventricular Dysfunction Complicated by CAWS Arteritis in DBA/2 Mice.

Authors:  Naoto Hirata; Ken-Ichi Ishibashi; Tatsuya Usui; Jiro Yoshioka; Satoru Hata; Yoshiyuki Adachi; Noriko Nagi-Miura; Shin Ohta; Naohito Ohno
Journal:  Int J Vasc Med       Date:  2012-07-08

10.  Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.

Authors:  Ryuji Ohashi; Ryuji Fukazawa; Makoto Watanabe; Hanako Tajima; Noriko Nagi-Miura; Naohito Ohno; Shinichi Tsuchiya; Yuh Fukuda; Shunichi Ogawa; Yasuhiko Itoh
Journal:  Int J Vasc Med       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.